438 related articles for article (PubMed ID: 11122160)
21. Flow cytometric analysis of the platelet surface area and surface density of glycoprotein IIb-IIIa of unactivated human platelets of various sizes.
Leytin V; Shapiro H; Novikov I; Radnay J
Biochem Biophys Res Commun; 1996 Sep; 226(1):94-100. PubMed ID: 8806597
[TBL] [Abstract][Full Text] [Related]
22. A familial platelet function disorder associated with abnormal signalling through the glycoprotein VI pathway.
Dunkley S; Arthur JF; Evans S; Gardiner EE; Shen Y; Andrews RK
Br J Haematol; 2007 Jun; 137(6):569-77. PubMed ID: 17539777
[TBL] [Abstract][Full Text] [Related]
23. Platelet hyporeactivity in very low birth weight neonates.
Rajasekhar D; Barnard MR; Bednarek FJ; Michelson AD
Thromb Haemost; 1997 May; 77(5):1002-7. PubMed ID: 9184418
[TBL] [Abstract][Full Text] [Related]
24. Low-density lipoprotein specifically binds glycoprotein IIb/IIIa: a flow cytometric method for ligand-receptor interaction.
Tetik S; Uras F; Ekşioğlu-Demiralp E; Turay Yardimci K
Clin Appl Thromb Hemost; 2008 Apr; 14(2):210-9. PubMed ID: 18160616
[TBL] [Abstract][Full Text] [Related]
25. Coordinated signaling through both G12/13 and G(i) pathways is sufficient to activate GPIIb/IIIa in human platelets.
Dorsam RT; Kim S; Jin J; Kunapuli SP
J Biol Chem; 2002 Dec; 277(49):47588-95. PubMed ID: 12297512
[TBL] [Abstract][Full Text] [Related]
26. Differential expression of a ligand induced binding site (LIBS) by GPIIb-IIIa ligand recognition peptides and parenteral antagonists.
Jennings LK; Haga JH; Slack SM
Thromb Haemost; 2000 Dec; 84(6):1095-102. PubMed ID: 11154119
[TBL] [Abstract][Full Text] [Related]
27. The heptapeptide LSARLAF mediates platelet activation through phospholipase Cgamma2 independently of glycoprotein IIb-IIIa.
Pearce AC; Wonerow P; Marshall SJ; Frampton J; Gartner TK; Watson SP
Biochem J; 2004 Feb; 378(Pt 1):193-9. PubMed ID: 14558887
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of fibrinogen binding and surface recruitment of GpIIb/IIIa as dose-dependent effects of the RGD-mimetic MK-852.
Wittig K; Rothe G; Schmitz G
Thromb Haemost; 1998 Mar; 79(3):625-30. PubMed ID: 9531053
[TBL] [Abstract][Full Text] [Related]
29. Interspecies comparison of platelet aggregation, LIBS expression and clot retraction: observed differences in GPIIb-IIIa functional activity.
Jennings LK; White MM; Mandrell TD
Thromb Haemost; 1995 Dec; 74(6):1551-6. PubMed ID: 8772236
[TBL] [Abstract][Full Text] [Related]
30. Differential ability of agonists to express distinct pools of fibrinogen (GpIIb/IIIa) receptors which can mediate the aggregation of human platelets.
Watts IS; Keery RJ; Lumley P
Thromb Haemost; 1989 Nov; 62(3):955-61. PubMed ID: 2512682
[TBL] [Abstract][Full Text] [Related]
31. A new murine monoclonal antibody reports an activation-dependent change in the conformation and/or microenvironment of the platelet glycoprotein IIb/IIIa complex.
Coller BS
J Clin Invest; 1985 Jul; 76(1):101-8. PubMed ID: 2991335
[TBL] [Abstract][Full Text] [Related]
32. A 1063G-->A mutation in exon 12 of glycoprotein (GP)IIb associated with a thrombasthenic phenotype: mutation analysis of [324E]GPIIb.
Tao J; Arias-Salgado EG; González-Manchón C; Iruín G; Butta N; Ayuso MS; Parrilla R
Br J Haematol; 2000 Dec; 111(3):965-73. PubMed ID: 11122161
[TBL] [Abstract][Full Text] [Related]
33. Reactive oxygen species and human platelet GP IIb/IIIa receptor activation.
Sill JC; Proper JA; Johnson ME; Uhl CB; Katusic ZS
Platelets; 2007 Dec; 18(8):613-9. PubMed ID: 18041653
[TBL] [Abstract][Full Text] [Related]
34. Targeting ligand-induced binding sites on GPIIb/IIIa via single-chain antibody allows effective anticoagulation without bleeding time prolongation.
Stoll P; Bassler N; Hagemeyer CE; Eisenhardt SU; Chen YC; Schmidt R; Schwarz M; Ahrens I; Katagiri Y; Pannen B; Bode C; Peter K
Arterioscler Thromb Vasc Biol; 2007 May; 27(5):1206-12. PubMed ID: 17322097
[TBL] [Abstract][Full Text] [Related]
35. Evidence for platelet alphaIIb beta3 activation despite elevated cytosolic cAMP.
Riondino S; Gazzaniga PP; Pulcinelli FM
Thromb Haemost; 2001 Feb; 85(2):320-5. PubMed ID: 11246555
[TBL] [Abstract][Full Text] [Related]
36. Identifying human platelet glycoproteins IIb and IIIa by capillary electrophoresis.
Vecchione G; Margaglione M; Grandone E; Colaizzo D; Cappucci G; Giuliani N; d'Addedda M; D'Andrea G; Nobile M; Amoriello A; Di Minno G
Electrophoresis; 1998 Jun; 19(8-9):1468-74. PubMed ID: 9694297
[TBL] [Abstract][Full Text] [Related]
37. Platelet anaesthesia during extracorporeal circulation: differential effects of GP IIb/IIIa blockers on platelet activation marker P-selectin expression at hypothermia.
Straub A; Schiebold D; Wendel HP; Azevedo R; Dietz K; Ziemer G
Thromb Res; 2008; 122(3):383-9. PubMed ID: 18304613
[TBL] [Abstract][Full Text] [Related]
38. Immunological comparisons of integrin alpha IIb beta 3 (GPIIb-IIIa) expressed on platelets and human erythroleukemia cells: evidence for cell specific differences.
Jennings LK; Slack SM; Wall CD; Mondoro TH
Blood Cells Mol Dis; 1996; 22(1):23-35. PubMed ID: 8807083
[TBL] [Abstract][Full Text] [Related]
39. Effects of platelet glycoprotein IIb-IIIa number and glycoprotein IIIa Leu33Pro polymorphism on platelet aggregation and sensitivity to glycoprotein IIb-IIIa antagonists.
Sirotkina OV; Khaspekova SG; Zabotina AM; Shimanova YV; Mazurov AV
Platelets; 2007 Nov; 18(7):506-14. PubMed ID: 17957566
[TBL] [Abstract][Full Text] [Related]
40. Potentiation of thromboxane A2-induced platelet secretion by Gi signaling through the phosphoinositide-3 kinase pathway.
Dangelmaier C; Jin J; Smith JB; Kunapuli SP
Thromb Haemost; 2001 Feb; 85(2):341-8. PubMed ID: 11246558
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]